Inebilizumab: First Approval
James E. Frampton
Topics & Concepts
Neuromyelitis opticaMedicineMyasthenia gravisImmunologyCD19AntibodyAutoantibodyDesensitization (medicine)Monoclonal antibodyRituximabInternal medicineReceptorMultiple Sclerosis Research StudiesImmunotherapy and Immune ResponsesSystemic Sclerosis and Related Diseases